Biofrontera Ratios (2020-2025) | BFRI

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter)
96.56%97.69%99.05%101.22%98.21%96.59%97.73%-72.27%47.93%52.60%98.93%112.80%47.98%44.61%45.88%58.03%61.95%70.74%70.74%82.40%
EBT Margin (Quarter)
-74.47%-61.78%-369.31%97.48%57.34%-19.07%-59.35%-27.44%-85.57%-167.97%-71.28%33.22%-131.90%-3.02%-62.87%-11.14%-48.95%-58.73%-95.06%32.98%
EBIT Margin (Quarter)
-73.78%-62.97%-371.60%12.78%-31.89%-139.38%-84.20%-55.02%-62.89%-148.75%-51.93%-36.48%-69.10%-64.69%-55.04%-13.63%-52.95%-56.25%-89.84%26.66%
EBITDA Margin (Quarter)
-73.78%-62.97%-371.60%12.78%-31.89%-139.38%-84.20%-55.02%-62.89%-148.75%-51.93%-36.48%-69.10%-64.69%-55.04%-13.63%-52.95%-56.25%-89.84%26.66%
Operating Margin (Quarter)
-73.78%-62.97%-371.60%12.78%-31.89%-139.38%-84.20%-55.02%-62.89%-148.75%-51.93%-36.48%-69.10%-64.69%-55.04%-13.63%-52.95%-56.25%-89.84%26.66%
Net Margin (Quarter)
-74.49%-62.53%-369.45%97.51%57.03%-19.07%-59.37%-27.45%-85.63%-168.21%-71.29%33.28%-131.91%-3.28%-62.91%-11.12%-48.94%-58.96%-95.15%46.04%
FCF Margin (Quarter)
-71.67%-18.92%-27.48%141.24%-21.59%1.84%-136.83%-81.83%-42.53%-196.02%-22.81%-83.59%-42.43%-59.92%-13.93%-7.97%-47.97%-34.15%-54.15%-14.12%
Efficiency
Inventory Average (Quarter)
4.95M4.67M6.84M10.45M9.63M6.92M13.49M8.91M5.43M5.24M6.59M6.59M5.28M4.18M2.88M
Assets Average (Quarter)
7.68M24.61M51.41M54.34M52.97M46.42M31.02M26.25M23.07M20.05M20.31M19.34M18.36M17.78M21.99M
Invested Capital (Quarter)
3.24M3.24M6.94M7.03M1.70M3.90M2.35M0.30M
Asset Utilization Ratio (Quarter)
0.010.210.070.070.540.601.101.271.531.761.841.962.132.091.90
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-41.67-43.38-40.267.51-31.10-36.39-0.01M-0.00M-271.84-107.44-80.52-3.85-4.11-16.53-285.33-37.89-7.15-62.786.27
Debt Ratio (Quarter)
405.250.060.140.170.050.140.100.01
Times Interest Earned (Quarter)
-41.67-43.38-40.267.51-31.10-36.39-0.01M-0.00M-271.84-107.44-80.52-3.85-4.11-16.53-285.33-37.89-7.15-62.786.27
Valuation
Enterprise Value (Quarter)
-1.72M-24.50M-22.40M-31.91M-27.50M-27.76M-8.90M-6.72M-1.42M-3.84M-4.39M-2.88M-5.91M-1.81M-7.21M-3.43M-6.41M
Return Ratios
Return on Sales (Quarter)
-0.01%-0.01%-0.04%0.01%0.01%0.00%-0.01%0.00%-0.01%-0.02%-0.01%0.00%-0.01%0.00%-0.01%0.00%0.00%-0.01%-0.01%0.00%
Return on Capital Employed (Quarter)
409.31%-202.54%-74.79%-39.95%-57.80%-80.56%-175.38%-185.40%-137.78%-214.83%-207.66%-194.26%1,232.83%-337.12%-112.39%
Return on Invested Capital (Quarter)
-0.08%-0.08%-0.03%-0.02%-0.02%-0.01%-0.01%-0.02%-0.02%-0.02%-0.03%-0.04%-0.11%
Return on Assets (Quarter)
-0.05%-0.01%-0.01%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%